Name

Model N

Legal name

Model N, Inc.

Website

https://modeln.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Redwood Shores

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Revenue: Subscription-based business model generating recurring revenue from cloud-based software licenses. Customers pay for access to the Revenue Cloud platform with annual or multi-year subscription contracts.
2. Professional Services: Value-added services including Advisory Services, Application Services, Value Realization Services, and Education Services that help customers implement and maximize value from the platform.
3. Legacy On-Premise Licenses: Historical on-premise license revenue, though company is transitioning from on-premise to cloud-first architecture (Revenue Cloud platform). Net retention rates above 110% indicate strong expansion within existing customer base.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Model N provides cloud-based Revenue Cloud SaaS platforms purpose-built for pharmaceutical, medical technology (medtech), and high-tech manufacturers. The platforms cover the full revenue lifecycle — pricing, contracting, deal execution, channel management, rebates, government pricing compliance (340B, Medicaid, state transparency), gross-to-net management, and revenue recognition — supported by professional services for implementation and ongoing customer success.

Product overview

Model N is a revenue optimization and compliance platform for life sciences and high-tech industries, delivered as a cloud-based SaaS solution with purpose-built products organized into three industry verticals: Pharma, Medtech, and High Tech. The platform architecture consists of core Revenue Cloud platforms for each industry, supported by specialized modules covering pricing management, contract management, government pricing compliance, 340B program management, channel management, deal management, rebate processing, and analytics. Key product families include: Global Pricing Management and Global Tender Management for international price coordination; Government Pricing, Medicaid, and 340B Vigilance for regulatory compliance; Provider Management and Payer Management for stakeholder relationships; Validata for claims validation; Data nSights and Intelligence Cloud for analytics and AI-driven insights; and Channel Data Management, Deal Management, and Rebate Management for high-tech sector needs. The platform connects commercial, pricing, contract, and revenue processes with ERP systems and downstream partners, serving over 150 companies across more than 120 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Data nSights: AI-ready integrated data and analytics solution for life sciences revenue management
• Revenue Cloud
• Intelligence Cloud
• 340B Vigilance

Products and services

• Revenue Cloud for Pharma

Quantifiable outcome

• $25 billion projected customer savings and 20x ROI based on customer value analyses
• +5 more outcomes

Named customers19 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature9 records

Partnerships

Six partnerships are on record, tiered core and minor.

• CCXcoreStrategic or Co-development Partner · 2 March 2026Strategic partnership to expand Model N's platform functionality into global market access, launch planning, and pricing strategy for life sciences companies. The collaboration enables pharmaceutical manufacturers to model, simulate, and coordinate launch strategies before products reach the market. CCX technology connects directly to Model N's global pricing and tender solutions, allowing manufacturers to model cross-market launch sequencing, evaluate MFN exposure, and reference pricing impacts using data-driven scenario modeling.
• OraclecoreTechnology or IntegrationStrategic integration partnership providing seamless connectivity with Oracle enterprise systems. Customers can integrate Model N's revenue management solutions with Oracle ERP and business applications.
• SAPcoreTechnology or IntegrationStrategic integration partnership providing seamless connectivity with SAP enterprise systems. Customers can integrate Model N's revenue management solutions with SAP ERP and business applications.
• SalesforcecoreTechnology or IntegrationStrategic partnership delivering access to key data and insights directly to Salesforce. Integration enables sales teams to leverage Model N pricing intelligence within their CRM workflows.
• Microsoft DynamicscoreTechnology or IntegrationStrategic integration partnership providing connectivity with Microsoft Dynamics enterprise systems for customers using Microsoft infrastructure.
• A-LIGNminorImplementation/ SI/ Consulting PartnerLeading compliance assessor that conducted Model N's ISO/IEC 27001 certification audit. A-LIGN is accredited by ANSI National Accreditation Board (ANAB) and UKAS to perform ISMS certifications.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Veeva Systems: Veeva is the dominant vertical cloud platform for life sciences, serving pharma and biotech with CRM, regulatory, quality, and clinical operations suites. While Model N specializes in revenue management/commercialization while Veeva spans clinical through commercial, both serve the same pharma buyer with regulated workflow SaaS — making Veeva both a partner and a potential adjacent competitor.
• SAP (Life Sciences solutions): SAP is both a strategic integration partner for Model N and a broad incumbent with native revenue management, contract management, and pricing capabilities within S/4HANA. SAP could expand native gross-to-net and rebate management features, potentially compressing Model N's value proposition for customers running SAP ERP.
• Salesforce (Life Sciences Cloud / Revenue Cloud): Salesforce is a Model N integration partner but also offers Life Sciences Cloud and Revenue Cloud capabilities (formerly Salesforce CPQ/Billing). For high-tech and pharma customers standardized on Salesforce, Salesforce's expanding native deal management and revenue intelligence could pressure Model N's pricing and channel data modules.
• IQVIA: IQVIA offers commercial analytics, real-world evidence, and life sciences technology platforms including contract and revenue management capabilities. It is a broader data-and-services incumbent that overlaps with Model N in pharma commercialization analytics and contract administration, particularly with mid-to-large manufacturers.

Direct peers

• ZINFI Technologies: ZINFI provides unified channel management software including partner relationship management, MDF management, and rebate management. It directly overlaps with Model N's High Tech vertical offerings (Channel Management, MDF, Rebate Management) for technology and semiconductor manufacturers.
• Icertis: Icertis is a contract lifecycle management (CLM) platform serving enterprise customers including pharma and high-tech manufacturers. Its Deal Management and contract intelligence capabilities overlap with Model N's Deal Management for Life Sciences and High Tech modules, particularly around pricing and contract compliance.
• Conga: Conga provides revenue management, contract management, and configure-price-quote (CPQ) solutions across multiple verticals including life sciences. It competes directly with Model N in deal/quote-to-revenue workflows for manufacturers and has a comparable quote-based enterprise SaaS model.
• Inmar (ThreeSixty): Inmar's ThreeSixty division provides pharma returns, chargeback processing, rebate administration, and contract management — directly overlapping Model N's Provider Management, Validata, and Rebate Management modules for pharmaceutical manufacturers.
• Kalderos (now part of Model N): Kalderos was the leading independent 340B drug discount intelligence and dispute resolution platform before being acquired by Model N in June 2026. Previously a direct competitor in the 340B space, now a wholly-owned subsidiary contributing the Truzo platform.

Emerging players

• Reltio: Reltio is a cloud-native master data management (MDM) and data unification platform with deep life sciences customers. While Model N operates at the application layer above MDM, Reltio's provider/payer data foundations overlap with Model N's Provider and Payer Management modules and could compete for the same data infrastructure budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/ModelNInc
• LinkedInlinkedin.com/company/modeln
• Xx.com/ModelN

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles30 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Model N